Digest Network Come funziona
Network
/
Società
Co
Non verificato

Contineum Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network

18 comunicati stampa

Guarda tutti i comunicati
15/05/2025
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Contineum Therapeutics to Present at the 2025 RBC Capital Markets Global Healthcare Conference
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
14/05/2025
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Reports First-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
28/04/2025
Mercato del lavoro
Finanza
Mercato azionario
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
Biotecnologia
Contineum Therapeutics Appoints Timothy Watkins, M.D., M.Sc., as Chief Medical Officer and Head of Development
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
17/03/2025
Mercato del lavoro
Scienza
Biotecnologia
Farmaceutica
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Contineum Therapeutics Announces Appointment of Diego Miralles, M.D. to Its Board of Directors
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
12/03/2025
Eventi
Web e Social Network
Salute
Sanità
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Contineum Therapeutics to Present at the Stifel 2025 Virtual CNS Forum
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
06/03/2025
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Reports Fourth-Quarter 2024 Financial Results; Affirms Key Clinical Development Milestones
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
04/03/2025
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Chronic Pain Trial of PIPE-791
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
03/03/2025
Biotecnologia
Farmaceutica
Salute
Eventi
Web e Social Network
Contineum Therapeutics to Present at the 2025 Leerink Partners Global Healthcare Conference
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
08/01/2025
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Contineum Therapeutics Completes Enrollment in Phase 2 PIPE-307 VISTA Trial for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0
16/12/2024
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Contineum Therapeutics Initiates Patient Dosing in Phase 1b Positron Emission Tomography (PET) Trial of PIPE-791
Fonte
Contineum Therapeutics, Inc.
Emittente
Business Wire
1,00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0